カテゴリー： 世界, 医療/バイオ, LP Information

世界の迅速抗菌薬感受性試験市場予測 2023年-2029年

【英語タイトル】Global Rapid Antimicrobial Susceptibility Testing Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02331）・商品コード：LP23DC02331
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：128
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の迅速抗菌薬感受性試験市場」は、過去の販売実績から2022年の世界の迅速抗菌薬感受性試験の総販売量を検討し、2023年から2029年の予測される迅速抗菌薬感受性試験の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の迅速抗菌薬感受性試験の市場規模を掲載し、XXX百万米ドル規模の世界の迅速抗菌薬感受性試験市場の詳細な分析を提供します。本インサイトレポートは、世界の迅速抗菌薬感受性試験業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の迅速抗菌薬感受性試験市場における各社の独自のポジションをより深く理解するために、迅速抗菌薬感受性試験製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の迅速抗菌薬感受性試験市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。迅速抗菌薬感受性試験の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。迅速抗菌薬感受性試験の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。迅速抗菌薬感受性試験のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

迅速抗菌薬感受性試験の世界主要メーカーとしては、BioMérieux、 BD、 Thermo Fisher Scientific、 Danaher、 Bio-Rad Laboratories、 Bruker、 Roche Diagnostics、 Accelerate Diagnostics、 Merck、 HiMedia Laboratories、 Liofilchem S.R.L Diagnostics、 Alifax S.r.l.、 Creative Diagnostics、 Synbiosis、 Bioanalyse、 ZHUHAI DL BIOTECH、 ELITechGroup、 Mast Group、 CONDALAB、 Genefluidics、 Biotron、 InvivoGen、 MP Biomedicals、 QuantaMatrix、 PML Microbiologicalsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の迅速抗菌薬感受性試験市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では迅速抗菌薬感受性試験市場をセグメンテーションし、種類別 (抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他)、用途別 (臨床診断、創薬、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他

・用途別区分：臨床診断、創薬、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の迅速抗菌薬感受性試験市場の10年間の市場状況・展望は？
・世界および地域別に見た迅速抗菌薬感受性試験市場成長の要因は何か？
・迅速抗菌薬感受性試験の市場機会はエンドマーケットの規模によってどのように変化するのか？
・迅速抗菌薬感受性試験のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：迅速抗菌薬感受性試験の年間販売量2018-2029、地域別現状・将来分析
・迅速抗菌薬感受性試験の種類別セグメント：抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他
・迅速抗菌薬感受性試験の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・迅速抗菌薬感受性試験の用途別セグメント：臨床診断、創薬、その他
・迅速抗菌薬感受性試験の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の迅速抗菌薬感受性試験市場
・企業別のグローバル迅速抗菌薬感受性試験市場データ：2018-2023年の年間販売量、市場シェア
・企業別の迅速抗菌薬感受性試験の年間売上：2018-2023年の売上、市場シェア
・企業別の迅速抗菌薬感受性試験販売価格
・主要企業の迅速抗菌薬感受性試験生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

迅速抗菌薬感受性試験の地域別レビュー
・地域別の迅速抗菌薬感受性試験市場規模2018-2023：年間販売量、売上
・主要国別の迅速抗菌薬感受性試験市場規模2018-2023：年間販売量、売上
・南北アメリカの迅速抗菌薬感受性試験販売の成長
・アジア太平洋の迅速抗菌薬感受性試験販売の成長
・ヨーロッパの迅速抗菌薬感受性試験販売の成長
・中東・アフリカの迅速抗菌薬感受性試験販売の成長

南北アメリカ市場
・南北アメリカの国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・南北アメリカの迅速抗菌薬感受性試験の種類別販売量
・南北アメリカの迅速抗菌薬感受性試験の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・アジア太平洋の迅速抗菌薬感受性試験の種類別販売量
・アジア太平洋の迅速抗菌薬感受性試験の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・ヨーロッパの迅速抗菌薬感受性試験の種類別販売量
・ヨーロッパの迅速抗菌薬感受性試験の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・中東・アフリカの迅速抗菌薬感受性試験の種類別販売量
・中東・アフリカの迅速抗菌薬感受性試験の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・迅速抗菌薬感受性試験の製造コスト構造分析
・迅速抗菌薬感受性試験の製造プロセス分析
・迅速抗菌薬感受性試験の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・迅速抗菌薬感受性試験の主要なグローバル販売業者
・迅速抗菌薬感受性試験の主要なグローバル顧客

地域別の迅速抗菌薬感受性試験市場予測レビュー
・地域別の迅速抗菌薬感受性試験市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・迅速抗菌薬感受性試験の種類別市場規模予測
・迅速抗菌薬感受性試験の用途別市場規模予測

主要企業分析
BioMérieux、 BD、 Thermo Fisher Scientific、 Danaher、 Bio-Rad Laboratories、 Bruker、 Roche Diagnostics、 Accelerate Diagnostics、 Merck、 HiMedia Laboratories、 Liofilchem S.R.L Diagnostics、 Alifax S.r.l.、 Creative Diagnostics、 Synbiosis、 Bioanalyse、 ZHUHAI DL BIOTECH、 ELITechGroup、 Mast Group、 CONDALAB、 Genefluidics、 Biotron、 InvivoGen、 MP Biomedicals、 QuantaMatrix、 PML Microbiologicals
・企業情報
・迅速抗菌薬感受性試験製品
・迅速抗菌薬感受性試験販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Rapid Antimicrobial Susceptibility Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rapid Antimicrobial Susceptibility Testing players cover BioMérieux, BD, Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, Bruker, Roche Diagnostics, Accelerate Diagnostics and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Susceptibility testing is used to determine which antimicrobials will inhibit the growth of the bacteria or fungi causing a specific infection.
LPI (LP Information)’ newest research report, the “Rapid Antimicrobial Susceptibility Testing Industry Forecast” looks at past sales and reviews total world Rapid Antimicrobial Susceptibility Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Antimicrobial Susceptibility Testing sales for 2023 through 2029. With Rapid Antimicrobial Susceptibility Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Antimicrobial Susceptibility Testing industry.
This Insight Report provides a comprehensive analysis of the global Rapid Antimicrobial Susceptibility Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Antimicrobial Susceptibility Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Antimicrobial Susceptibility Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Antimicrobial Susceptibility Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Antimicrobial Susceptibility Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Antimicrobial Susceptibility Testing market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Others
Segmentation by application
Clinical Diagnostics
Drug Development
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BioMérieux
BD
Thermo Fisher Scientific
Danaher
Bio-Rad Laboratories
Bruker
Roche Diagnostics
Accelerate Diagnostics
Merck
HiMedia Laboratories
Liofilchem S.R.L Diagnostics
Alifax S.r.l.
Creative Diagnostics
Synbiosis
Bioanalyse
ZHUHAI DL BIOTECH
ELITechGroup
Mast Group
CONDALAB
Genefluidics
Biotron
InvivoGen
MP Biomedicals
QuantaMatrix
PML Microbiologicals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rapid Antimicrobial Susceptibility Testing market?
What factors are driving Rapid Antimicrobial Susceptibility Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rapid Antimicrobial Susceptibility Testing market opportunities vary by end market size?
How does Rapid Antimicrobial Susceptibility Testing break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rapid Antimicrobial Susceptibility Testing by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rapid Antimicrobial Susceptibility Testing by Country/Region, 2018, 2022 & 2029
2.2 Rapid Antimicrobial Susceptibility Testing Segment by Type
2.2.1 Antibacterial Susceptibility Testing
2.2.2 Antifungal Susceptibility Testing
2.2.3 Antiparasitic Susceptibility Testing
2.2.4 Others
2.3 Rapid Antimicrobial Susceptibility Testing Sales by Type
2.3.1 Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type (2018-2023)
2.3.2 Global Rapid Antimicrobial Susceptibility Testing Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rapid Antimicrobial Susceptibility Testing Sale Price by Type (2018-2023)
2.4 Rapid Antimicrobial Susceptibility Testing Segment by Application
2.4.1 Clinical Diagnostics
2.4.2 Drug Development
2.4.3 Other
2.5 Rapid Antimicrobial Susceptibility Testing Sales by Application
2.5.1 Global Rapid Antimicrobial Susceptibility Testing Sale Market Share by Application (2018-2023)
2.5.2 Global Rapid Antimicrobial Susceptibility Testing Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rapid Antimicrobial Susceptibility Testing Sale Price by Application (2018-2023)
3 Global Rapid Antimicrobial Susceptibility Testing by Company
3.1 Global Rapid Antimicrobial Susceptibility Testing Breakdown Data by Company
3.1.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales by Company (2018-2023)
3.1.2 Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Company (2018-2023)
3.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue by Company (2018-2023)
3.2.1 Global Rapid Antimicrobial Susceptibility Testing Revenue by Company (2018-2023)
3.2.2 Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Company (2018-2023)
3.3 Global Rapid Antimicrobial Susceptibility Testing Sale Price by Company
3.4 Key Manufacturers Rapid Antimicrobial Susceptibility Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rapid Antimicrobial Susceptibility Testing Product Location Distribution
3.4.2 Players Rapid Antimicrobial Susceptibility Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rapid Antimicrobial Susceptibility Testing by Geographic Region
4.1 World Historic Rapid Antimicrobial Susceptibility Testing Market Size by Geographic Region (2018-2023)
4.1.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rapid Antimicrobial Susceptibility Testing Market Size by Country/Region (2018-2023)
4.2.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rapid Antimicrobial Susceptibility Testing Sales Growth
4.4 APAC Rapid Antimicrobial Susceptibility Testing Sales Growth
4.5 Europe Rapid Antimicrobial Susceptibility Testing Sales Growth
4.6 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Growth
5 Americas
5.1 Americas Rapid Antimicrobial Susceptibility Testing Sales by Country
5.1.1 Americas Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023)
5.1.2 Americas Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023)
5.2 Americas Rapid Antimicrobial Susceptibility Testing Sales by Type
5.3 Americas Rapid Antimicrobial Susceptibility Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid Antimicrobial Susceptibility Testing Sales by Region
6.1.1 APAC Rapid Antimicrobial Susceptibility Testing Sales by Region (2018-2023)
6.1.2 APAC Rapid Antimicrobial Susceptibility Testing Revenue by Region (2018-2023)
6.2 APAC Rapid Antimicrobial Susceptibility Testing Sales by Type
6.3 APAC Rapid Antimicrobial Susceptibility Testing Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rapid Antimicrobial Susceptibility Testing by Country
7.1.1 Europe Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023)
7.1.2 Europe Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023)
7.2 Europe Rapid Antimicrobial Susceptibility Testing Sales by Type
7.3 Europe Rapid Antimicrobial Susceptibility Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rapid Antimicrobial Susceptibility Testing by Country
8.1.1 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023)
8.2 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Type
8.3 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rapid Antimicrobial Susceptibility Testing
10.3 Manufacturing Process Analysis of Rapid Antimicrobial Susceptibility Testing
10.4 Industry Chain Structure of Rapid Antimicrobial Susceptibility Testing
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rapid Antimicrobial Susceptibility Testing Distributors
11.3 Rapid Antimicrobial Susceptibility Testing Customer
12 World Forecast Review for Rapid Antimicrobial Susceptibility Testing by Geographic Region
12.1 Global Rapid Antimicrobial Susceptibility Testing Market Size Forecast by Region
12.1.1 Global Rapid Antimicrobial Susceptibility Testing Forecast by Region (2024-2029)
12.1.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rapid Antimicrobial Susceptibility Testing Forecast by Type
12.7 Global Rapid Antimicrobial Susceptibility Testing Forecast by Application
13 Key Players Analysis
13.1 BioMérieux
13.1.1 BioMérieux Company Information
13.1.2 BioMérieux Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.1.3 BioMérieux Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioMérieux Main Business Overview
13.1.5 BioMérieux Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.2.3 BD Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Information
13.3.2 Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Thermo Fisher Scientific Main Business Overview
13.3.5 Thermo Fisher Scientific Latest Developments
13.4 Danaher
13.4.1 Danaher Company Information
13.4.2 Danaher Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.4.3 Danaher Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Danaher Main Business Overview
13.4.5 Danaher Latest Developments
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Information
13.5.2 Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.5.3 Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bio-Rad Laboratories Main Business Overview
13.5.5 Bio-Rad Laboratories Latest Developments
13.6 Bruker
13.6.1 Bruker Company Information
13.6.2 Bruker Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.6.3 Bruker Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bruker Main Business Overview
13.6.5 Bruker Latest Developments
13.7 Roche Diagnostics
13.7.1 Roche Diagnostics Company Information
13.7.2 Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.7.3 Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Roche Diagnostics Main Business Overview
13.7.5 Roche Diagnostics Latest Developments
13.8 Accelerate Diagnostics
13.8.1 Accelerate Diagnostics Company Information
13.8.2 Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.8.3 Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Accelerate Diagnostics Main Business Overview
13.8.5 Accelerate Diagnostics Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.9.3 Merck Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 HiMedia Laboratories
13.10.1 HiMedia Laboratories Company Information
13.10.2 HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.10.3 HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 HiMedia Laboratories Main Business Overview
13.10.5 HiMedia Laboratories Latest Developments
13.11 Liofilchem S.R.L Diagnostics
13.11.1 Liofilchem S.R.L Diagnostics Company Information
13.11.2 Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.11.3 Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Liofilchem S.R.L Diagnostics Main Business Overview
13.11.5 Liofilchem S.R.L Diagnostics Latest Developments
13.12 Alifax S.r.l.
13.12.1 Alifax S.r.l. Company Information
13.12.2 Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.12.3 Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Alifax S.r.l. Main Business Overview
13.12.5 Alifax S.r.l. Latest Developments
13.13 Creative Diagnostics
13.13.1 Creative Diagnostics Company Information
13.13.2 Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.13.3 Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Creative Diagnostics Main Business Overview
13.13.5 Creative Diagnostics Latest Developments
13.14 Synbiosis
13.14.1 Synbiosis Company Information
13.14.2 Synbiosis Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.14.3 Synbiosis Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Synbiosis Main Business Overview
13.14.5 Synbiosis Latest Developments
13.15 Bioanalyse
13.15.1 Bioanalyse Company Information
13.15.2 Bioanalyse Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.15.3 Bioanalyse Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Bioanalyse Main Business Overview
13.15.5 Bioanalyse Latest Developments
13.16 ZHUHAI DL BIOTECH
13.16.1 ZHUHAI DL BIOTECH Company Information
13.16.2 ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.16.3 ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 ZHUHAI DL BIOTECH Main Business Overview
13.16.5 ZHUHAI DL BIOTECH Latest Developments
13.17 ELITechGroup
13.17.1 ELITechGroup Company Information
13.17.2 ELITechGroup Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.17.3 ELITechGroup Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 ELITechGroup Main Business Overview
13.17.5 ELITechGroup Latest Developments
13.18 Mast Group
13.18.1 Mast Group Company Information
13.18.2 Mast Group Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.18.3 Mast Group Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Mast Group Main Business Overview
13.18.5 Mast Group Latest Developments
13.19 CONDALAB
13.19.1 CONDALAB Company Information
13.19.2 CONDALAB Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.19.3 CONDALAB Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 CONDALAB Main Business Overview
13.19.5 CONDALAB Latest Developments
13.20 Genefluidics
13.20.1 Genefluidics Company Information
13.20.2 Genefluidics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.20.3 Genefluidics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Genefluidics Main Business Overview
13.20.5 Genefluidics Latest Developments
13.21 Biotron
13.21.1 Biotron Company Information
13.21.2 Biotron Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.21.3 Biotron Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Biotron Main Business Overview
13.21.5 Biotron Latest Developments
13.22 InvivoGen
13.22.1 InvivoGen Company Information
13.22.2 InvivoGen Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.22.3 InvivoGen Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 InvivoGen Main Business Overview
13.22.5 InvivoGen Latest Developments
13.23 MP Biomedicals
13.23.1 MP Biomedicals Company Information
13.23.2 MP Biomedicals Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.23.3 MP Biomedicals Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 MP Biomedicals Main Business Overview
13.23.5 MP Biomedicals Latest Developments
13.24 QuantaMatrix
13.24.1 QuantaMatrix Company Information
13.24.2 QuantaMatrix Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.24.3 QuantaMatrix Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 QuantaMatrix Main Business Overview
13.24.5 QuantaMatrix Latest Developments
13.25 PML Microbiologicals
13.25.1 PML Microbiologicals Company Information
13.25.2 PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.25.3 PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 PML Microbiologicals Main Business Overview
13.25.5 PML Microbiologicals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rapid Antimicrobial Susceptibility Testing Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rapid Antimicrobial Susceptibility Testing Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antibacterial Susceptibility Testing
Table 4. Major Players of Antifungal Susceptibility Testing
Table 5. Major Players of Antiparasitic Susceptibility Testing
Table 6. Major Players of Others
Table 7. Global Rapid Antimicrobial Susceptibility Testing Sales by Type (2018-2023) & (K Units)
Table 8. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type (2018-2023)
Table 9. Global Rapid Antimicrobial Susceptibility Testing Revenue by Type (2018-2023) & ($ million)
Table 10. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Type (2018-2023)
Table 11. Global Rapid Antimicrobial Susceptibility Testing Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Rapid Antimicrobial Susceptibility Testing Sales by Application (2018-2023) & (K Units)
Table 13. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Application (2018-2023)
Table 14. Global Rapid Antimicrobial Susceptibility Testing Revenue by Application (2018-2023)
Table 15. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Application (2018-2023)
Table 16. Global Rapid Antimicrobial Susceptibility Testing Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Rapid Antimicrobial Susceptibility Testing Sales by Company (2018-2023) & (K Units)
Table 18. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Company (2018-2023)
Table 19. Global Rapid Antimicrobial Susceptibility Testing Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Company (2018-2023)
Table 21. Global Rapid Antimicrobial Susceptibility Testing Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Rapid Antimicrobial Susceptibility Testing Producing Area Distribution and Sales Area
Table 23. Players Rapid Antimicrobial Susceptibility Testing Products Offered
Table 24. Rapid Antimicrobial Susceptibility Testing Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rapid Antimicrobial Susceptibility Testing Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share Geographic Region (2018-2023)
Table 29. Global Rapid Antimicrobial Susceptibility Testing Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Rapid Antimicrobial Susceptibility Testing Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Country/Region (2018-2023)
Table 33. Global Rapid Antimicrobial Susceptibility Testing Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023) & (K Units)
Table 36. Americas Rapid Antimicrobial Susceptibility Testing Sales Market Share by Country (2018-2023)
Table 37. Americas Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Country (2018-2023)
Table 39. Americas Rapid Antimicrobial Susceptibility Testing Sales by Type (2018-2023) & (K Units)
Table 40. Americas Rapid Antimicrobial Susceptibility Testing Sales by Application (2018-2023) & (K Units)
Table 41. APAC Rapid Antimicrobial Susceptibility Testing Sales by Region (2018-2023) & (K Units)
Table 42. APAC Rapid Antimicrobial Susceptibility Testing Sales Market Share by Region (2018-2023)
Table 43. APAC Rapid Antimicrobial Susceptibility Testing Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Region (2018-2023)
Table 45. APAC Rapid Antimicrobial Susceptibility Testing Sales by Type (2018-2023) & (K Units)
Table 46. APAC Rapid Antimicrobial Susceptibility Testing Sales by Application (2018-2023) & (K Units)
Table 47. Europe Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023) & (K Units)
Table 48. Europe Rapid Antimicrobial Susceptibility Testing Sales Market Share by Country (2018-2023)
Table 49. Europe Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Country (2018-2023)
Table 51. Europe Rapid Antimicrobial Susceptibility Testing Sales by Type (2018-2023) & (K Units)
Table 52. Europe Rapid Antimicrobial Susceptibility Testing Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rapid Antimicrobial Susceptibility Testing
Table 60. Key Market Challenges & Risks of Rapid Antimicrobial Susceptibility Testing
Table 61. Key Industry Trends of Rapid Antimicrobial Susceptibility Testing
Table 62. Rapid Antimicrobial Susceptibility Testing Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rapid Antimicrobial Susceptibility Testing Distributors List
Table 65. Rapid Antimicrobial Susceptibility Testing Customer List
Table 66. Global Rapid Antimicrobial Susceptibility Testing Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Rapid Antimicrobial Susceptibility Testing Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Rapid Antimicrobial Susceptibility Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Rapid Antimicrobial Susceptibility Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Rapid Antimicrobial Susceptibility Testing Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Rapid Antimicrobial Susceptibility Testing Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Rapid Antimicrobial Susceptibility Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Rapid Antimicrobial Susceptibility Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Rapid Antimicrobial Susceptibility Testing Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Rapid Antimicrobial Susceptibility Testing Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Rapid Antimicrobial Susceptibility Testing Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Rapid Antimicrobial Susceptibility Testing Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. BioMérieux Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 81. BioMérieux Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 82. BioMérieux Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. BioMérieux Main Business
Table 84. BioMérieux Latest Developments
Table 85. BD Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 86. BD Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 87. BD Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. BD Main Business
Table 89. BD Latest Developments
Table 90. Thermo Fisher Scientific Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 91. Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 92. Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Thermo Fisher Scientific Main Business
Table 94. Thermo Fisher Scientific Latest Developments
Table 95. Danaher Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 96. Danaher Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 97. Danaher Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Danaher Main Business
Table 99. Danaher Latest Developments
Table 100. Bio-Rad Laboratories Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 101. Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 102. Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Bio-Rad Laboratories Main Business
Table 104. Bio-Rad Laboratories Latest Developments
Table 105. Bruker Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 106. Bruker Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 107. Bruker Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Bruker Main Business
Table 109. Bruker Latest Developments
Table 110. Roche Diagnostics Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 111. Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 112. Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Roche Diagnostics Main Business
Table 114. Roche Diagnostics Latest Developments
Table 115. Accelerate Diagnostics Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 116. Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 117. Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Accelerate Diagnostics Main Business
Table 119. Accelerate Diagnostics Latest Developments
Table 120. Merck Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 121. Merck Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 122. Merck Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Merck Main Business
Table 124. Merck Latest Developments
Table 125. HiMedia Laboratories Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 126. HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 127. HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. HiMedia Laboratories Main Business
Table 129. HiMedia Laboratories Latest Developments
Table 130. Liofilchem S.R.L Diagnostics Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 131. Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 132. Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Liofilchem S.R.L Diagnostics Main Business
Table 134. Liofilchem S.R.L Diagnostics Latest Developments
Table 135. Alifax S.r.l. Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 136. Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 137. Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Alifax S.r.l. Main Business
Table 139. Alifax S.r.l. Latest Developments
Table 140. Creative Diagnostics Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 141. Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 142. Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Creative Diagnostics Main Business
Table 144. Creative Diagnostics Latest Developments
Table 145. Synbiosis Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 146. Synbiosis Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 147. Synbiosis Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Synbiosis Main Business
Table 149. Synbiosis Latest Developments
Table 150. Bioanalyse Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 151. Bioanalyse Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 152. Bioanalyse Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Bioanalyse Main Business
Table 154. Bioanalyse Latest Developments
Table 155. ZHUHAI DL BIOTECH Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 156. ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 157. ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. ZHUHAI DL BIOTECH Main Business
Table 159. ZHUHAI DL BIOTECH Latest Developments
Table 160. ELITechGroup Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 161. ELITechGroup Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 162. ELITechGroup Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. ELITechGroup Main Business
Table 164. ELITechGroup Latest Developments
Table 165. Mast Group Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 166. Mast Group Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 167. Mast Group Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Mast Group Main Business
Table 169. Mast Group Latest Developments
Table 170. CONDALAB Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 171. CONDALAB Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 172. CONDALAB Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. CONDALAB Main Business
Table 174. CONDALAB Latest Developments
Table 175. Genefluidics Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 176. Genefluidics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 177. Genefluidics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Genefluidics Main Business
Table 179. Genefluidics Latest Developments
Table 180. Biotron Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 181. Biotron Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 182. Biotron Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 183. Biotron Main Business
Table 184. Biotron Latest Developments
Table 185. InvivoGen Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 186. InvivoGen Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 187. InvivoGen Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 188. InvivoGen Main Business
Table 189. InvivoGen Latest Developments
Table 190. MP Biomedicals Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 191. MP Biomedicals Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 192. MP Biomedicals Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 193. MP Biomedicals Main Business
Table 194. MP Biomedicals Latest Developments
Table 195. QuantaMatrix Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 196. QuantaMatrix Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 197. QuantaMatrix Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 198. QuantaMatrix Main Business
Table 199. QuantaMatrix Latest Developments
Table 200. PML Microbiologicals Basic Information, Rapid Antimicrobial Susceptibility Testing Manufacturing Base, Sales Area and Its Competitors
Table 201. PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
Table 202. PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 203. PML Microbiologicals Main Business
Table 204. PML Microbiologicals Latest Developments
List of Figures
Figure 1. Picture of Rapid Antimicrobial Susceptibility Testing
Figure 2. Rapid Antimicrobial Susceptibility Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rapid Antimicrobial Susceptibility Testing Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rapid Antimicrobial Susceptibility Testing Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rapid Antimicrobial Susceptibility Testing Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antibacterial Susceptibility Testing
Figure 10. Product Picture of Antifungal Susceptibility Testing
Figure 11. Product Picture of Antiparasitic Susceptibility Testing
Figure 12. Product Picture of Others
Figure 13. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type in 2022
Figure 14. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Type (2018-2023)
Figure 15. Rapid Antimicrobial Susceptibility Testing Consumed in Clinical Diagnostics
Figure 16. Global Rapid Antimicrobial Susceptibility Testing Market: Clinical Diagnostics (2018-2023) & (K Units)
Figure 17. Rapid Antimicrobial Susceptibility Testing Consumed in Drug Development
Figure 18. Global Rapid Antimicrobial Susceptibility Testing Market: Drug Development (2018-2023) & (K Units)
Figure 19. Rapid Antimicrobial Susceptibility Testing Consumed in Other
Figure 20. Global Rapid Antimicrobial Susceptibility Testing Market: Other (2018-2023) & (K Units)
Figure 21. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Application (2022)
Figure 22. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Application in 2022
Figure 23. Rapid Antimicrobial Susceptibility Testing Sales Market by Company in 2022 (K Units)
Figure 24. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Company in 2022
Figure 25. Rapid Antimicrobial Susceptibility Testing Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Company in 2022
Figure 27. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Rapid Antimicrobial Susceptibility Testing Sales 2018-2023 (K Units)
Figure 30. Americas Rapid Antimicrobial Susceptibility Testing Revenue 2018-2023 ($ Millions)
Figure 31. APAC Rapid Antimicrobial Susceptibility Testing Sales 2018-2023 (K Units)
Figure 32. APAC Rapid Antimicrobial Susceptibility Testing Revenue 2018-2023 ($ Millions)
Figure 33. Europe Rapid Antimicrobial Susceptibility Testing Sales 2018-2023 (K Units)
Figure 34. Europe Rapid Antimicrobial Susceptibility Testing Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Revenue 2018-2023 ($ Millions)
Figure 37. Americas Rapid Antimicrobial Susceptibility Testing Sales Market Share by Country in 2022
Figure 38. Americas Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Country in 2022
Figure 39. Americas Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type (2018-2023)
Figure 40. Americas Rapid Antimicrobial Susceptibility Testing Sales Market Share by Application (2018-2023)
Figure 41. United States Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Rapid Antimicrobial Susceptibility Testing Sales Market Share by Region in 2022
Figure 46. APAC Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Regions in 2022
Figure 47. APAC Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type (2018-2023)
Figure 48. APAC Rapid Antimicrobial Susceptibility Testing Sales Market Share by Application (2018-2023)
Figure 49. China Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Rapid Antimicrobial Susceptibility Testing Sales Market Share by Country in 2022
Figure 57. Europe Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Country in 2022
Figure 58. Europe Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type (2018-2023)
Figure 59. Europe Rapid Antimicrobial Susceptibility Testing Sales Market Share by Application (2018-2023)
Figure 60. Germany Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Market Share by Application (2018-2023)
Figure 69. Egypt Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Rapid Antimicrobial Susceptibility Testing Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Rapid Antimicrobial Susceptibility Testing in 2022
Figure 75. Manufacturing Process Analysis of Rapid Antimicrobial Susceptibility Testing
Figure 76. Industry Chain Structure of Rapid Antimicrobial Susceptibility Testing
Figure 77. Channels of Distribution
Figure 78. Global Rapid Antimicrobial Susceptibility Testing Sales Market Forecast by Region (2024-2029)
Figure 79. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の迅速抗菌薬感受性試験市場予測 2023年-2029年] (コード：LP23DC02331)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の迅速抗菌薬感受性試験市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のマイコプラズマ用迅速検出キット市場予測 2023年-2029年
  • 世界の細菌用識別&感受性システム市場予測 2023年-2029年
  • 世界の交流磁化率測定装置市場予測 2023年-2029年
  • 世界の口腔液研究用薬物検査市場予測 2023年-2029年
  • 世界の抗菌シリコーンゴム市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆